Thank you, Mr. Chair.
My thanks to the guests for being here today.
Following on Ms. Laverdière's questions, I am going to try to understand a little more about the development of a malaria vaccine.
What is the difference between malaria and other diseases afflicting the world?
Are we seeing mutations in the disease? Are we still trying to develop new vaccines. In what way does the nature of malaria make that task so difficult?
My colleague the senator could begin, perhaps.